Atorvastatin: Clinical Trials

200 trials of Atorvastatin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

126 completed, 26 unknown, 19 recruiting, 13 terminated. 200 Phase 2, 27 Phase 3, 18 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2200Completed 126, Unknown 26, Recruiting 19, Terminated 13, Active not recruiting 4, Not yet recruiting 4, Enrolling by invitation 3, Withdrawn 3, Suspended 2
Phase 327Completed 16, Unknown 7, Not yet recruiting 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 118Completed 8, Unknown 4, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1, Suspended 1, Terminated 1, Withdrawn 1

Follow Atorvastatin: new trials by email Literature Review of Atorvastatin trials Research Report on Atorvastatin

Trials (filtered) newest first · largest first

All 200 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period.
Allogeneic umbilical cord mesenchymal stem cell, Aspirin Enteric-coated Tablets & Atorvastatin Calcium - Cerebral Infarction
Phase 1 / Phase 2SuspendedSclnow Biotechnology Co., Ltd.402026-12-312026-04-23
Prophylactic Treatment of Graves Ophthalmopathy (GO) in Newly Diagnosed Graves' Disease (GD) With Atorvastatin (ATORGO)
Atorvastatin - Graves Disease, Graves Disease (Basedow's Disease)
Phase 2Not yet recruitingRegion Skane5542026-11-012026-10-20
Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin
Standard of Care + atorvastatin, Standard of Care (SOC) - Ovarian Cancer, Fallopian Tube Cancers
Phase 2Not yet recruitingUniversity of Colorado, Denver402026-09-012026-09-11
Pharmacologic Therapies to Mitigate Radiation- Associated Heart Disease
Atorvastatin and Lisinopril, Placebo - Chest Wall Tumor, Breast Cancer
Phase 2RecruitingUNC Lineberger Comprehensive Cancer Center602026-08-122026-09-17
A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID
Maraviroc (MVC), Atorvastatin, 10mg, 20mg, 40mg, Placebo, Maraviroc - Long COVID
Phase 2 / Phase 3Not yet recruitingHealthBio, Inc.2522026-07-152026-06-18
PTC-Guided Atorvastatin Plus Axitinib and Toripalimab in Advanced RCC
Axitinib, Toripalimab, Atorvastatin - Advanced Renal Cell Carcinoma (RCC), PTC
Phase 1 / Phase 2Not yet recruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences402026-05-142026-06-05
Prospective Management of Plaque Instability With Statins and Extra Folic Acid
Atorvastatin plus folic acid, Atorvastatin - Carotid Atherosclerotic Plaque
Phase 1 / Phase 2RecruitingRuijin Hospital1802026-03-012026-07-02
ATORvastatin in Pulmonary TUBerculosis: a POPulation PharmacoKinetics -PharmacoDynamics Sub-study (ATORTUB popPK-PD)
Atorvastatin 20 mg, Atorvastatin 40 mg, Atorvastatin 60 mg - Pulmonary Tuberculosis (TB)
Phase 2RecruitingObafemi Awolowo University Teaching Hospital802026-01-032026-01-23
Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis
Atorvastatin 20 mg, Placebo - Decompensated Liver Cirrhosis, Cirrhosis
Phase 2RecruitingCAMC Health System502025-09-092026-02-25
Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
statin + ezetimibe, Statin monotherapy (rosuvastatin or atorvastatin) - Ischemic Stroke, Hypercholesteremia
Phase 2RecruitingChang Gung Memorial Hospital3002025-08-012025-12-30
Statin Effect on Arrhythmogenic Cardiomyopathy Disease Progression (SEARCH)
Atorvastatin 80 mg/day, Placebo atorvastatin - Arrhythmogenic Cardiomyopathy
Phase 2RecruitingCentro Cardiologico Monzino1022025-03-312026-10-26
A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Treatment With Focus on Mechanisms of Resistance to Endocrine Treatment (Fulvestrant/Aromatase Inhibitors) in Patients With Advanced Breast Cancer
Letrozole, Letrozole and atorvastatin, Fulvestrant - Breast Cancer
Phase 2CompletedLund University Hospital1262025-01-022025-09-10
High-Dose Rosuvastatin Preloading for Enhanced Outcomes in STEMI Patients Undergoing Primary PCI
Statin monotherapy (rosuvastatin or atorvastatin), Placebo - ST Elevation (STEMI) Myocardial Infarction
Phase 2Active not recruitingSheikh Zayed Federal Postgraduate Medical Institute662024-12-022025-04-11
Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke
PCSK9 inhibitors combined with atorvastatin/rosuvastatin, Atorvastatin/Rosuvastatin - Acute Ischemic Stroke
Phase 2 / Phase 3CompletedXiang Luo4292024-11-292026-06-09
Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet
Atorvastatin 10mg, Modification of dietary fat composition - Epilepsy, Dyslipidemia
Phase 1 / Phase 2Enrolling by invitationJohns Hopkins University222024-10-042026-10-19
Atorvastatin for Preventing Disease Metastasis in Patients With Resected High-Risk Stage IIA, IIB, or IIIA Melanoma
Atorvastatin, Placebo Administration, Computed Tomography - Pathologic Stage IIIA Cutaneous Melanoma AJCC v8, Pathologic Stage IIA Cutaneous Melanoma AJCC v8
Phase 2Active not recruitingOHSU Knight Cancer Institute1502024-09-012026-03-13
Statins Effect on Incidence of Side Effects of Platinum Based Chemotherapy
Statin - Solid Tumors, Ototoxicity
Phase 1 / Phase 2CompletedMinia University562024-09-012026-01-20
Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury
Atorvastatin Calcium, Minocycline Hydrochloride, Candesartan Cilexetil - Traumatic Brain Injury
Phase 2Enrolling by invitationUniversity of California, San Francisco6722024-08-012025-12-22
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Placebo, Atorvastatin - Hearing Loss, Head and Neck Cancer
Phase 2RecruitingNational Institute on Deafness and Other Communication Disorders (NIDCD)2242024-07-102026-09-02
Prophylactic Treatment With Atorvastatin for Episodic Migraine.
Atorvastatin 40mg, Placebo, Atorvastatin 20mg - Episodic Migraine
Phase 2RecruitingSt. Olavs Hospital4502024-05-012026-07-14

Showing 20 of 200. Sign in to see all of them.

Conditions studied

Hypercholesterolemia (22)  ·  Dyslipidemias (16)  ·  Hyperlipidemias (15)  ·  Breast Neoplasms (12)  ·  Cardiovascular Diseases (8)  ·  Diabetes Mellitus (7)  ·  Metabolic Syndrome (5)  ·  Myocardial Infarction (5)  ·  Prostatic Neoplasms (5)  ·  Tuberculosis (5)  ·  Cardiotoxicity (4)  ·  Chronic Periodontitis (4)  ·  Inflammation (4)  ·  Ischemic Stroke (4)  ·  Stroke (4)

Sponsors

Tanta University (5)  ·  Aegerion Pharmaceuticals, Inc. (4)  ·  Eli Lilly and Company (4)  ·  Government Dental College and Research Institute, Bangalore (4)  ·  M.D. Anderson Cancer Center (4)  ·  University Health Network, Toronto (4)  ·  Esperion Therapeutics, Inc. (3)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (3)  ·  Obafemi Awolowo University Teaching Hospital (3)  ·  Peking University People's Hospital (3)  ·  Sanofi (3)  ·  AstraZeneca (2)  ·  Chang Gung Memorial Hospital (2)  ·  Chinese Academy of Medical Sciences, Fuwai Hospital (2)  ·  Damanhour University (2)

Countries

United States (89)  ·  China (19)  ·  Canada (13)  ·  Egypt (11)  ·  Denmark (8)  ·  Italy (8)  ·  Taiwan (6)  ·  Mexico (5)  ·  United Kingdom (5)  ·  Netherlands (4)  ·  Sweden (4)  ·  Australia (3)  ·  Brazil (3)  ·  France (3)  ·  India (3)

Top investigators

Bolanle A Omotoso, MD (3)  ·  Amira B Kassem, PhD (2)  ·  Chivers Woodruff, Jr, MD (2)  ·  Cynthia Strout, MD (2)  ·  Dennis McCluskey, MD (2)  ·  Frank H Christensen, MD (2)  ·  Harry Geisberg, MD (2)  ·  James Zavoral, MD (2)  ·  Jeff Geohas, MD (2)  ·  Linda Murray, MD (2)  ·  Linn H Steffensen, Associate Professor II (2)  ·  Marco Mielcarek (2)

Results publications

PMID 38018702, PMID 30183102, PMID 25060413, PMID 25660356, PMID 26872608, PMID 11877368, PMID 15207950, PMID 15883262, PMID 17118406, PMID 17384435, PMID 19073787, PMID 19201496, PMID 19208914, PMID 19421322, PMID 19929989, PMID 19932542, PMID 20003436, PMID 20110022, PMID 20204386, PMID 20339006, PMID 20863951, PMID 20923537, PMID 21067804, PMID 21144505, PMID 21166928, PMID 21310077, PMID 21473764, PMID 21518985, PMID 21752880, PMID 21958521, PMID 22089718, PMID 22117606, PMID 22140269, PMID 22169113, PMID 22175654, PMID 22209480, PMID 22264573, PMID 22362846, PMID 22459680, PMID 22463922, PMID 22606998, PMID 23040716, PMID 23113833, PMID 23482473, PMID 24256611, PMID 25047021, PMID 25095746, PMID 25103444, PMID 25175924, PMID 25771069

NIH funding

P30CA015704 (2), 2004 (1), 2005 (1), 2016 (1), 2023 (1), K23AG026752 (1), K23GM101463 (1), N01CN35000 (1), P01CA018029 (1), P30CA015083 (1), P30CA060553 (1), R01HL065176 (1), R01HL075771 (1), R01HL108307 (1), R01HL111659 (1)